LENZ Therapeutics Statistics
Total Valuation
LENZ has a market cap or net worth of $291.28 million. The enterprise value is $3.20 million.
Important Dates
The next estimated earnings date is Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LENZ has 31.35 million shares outstanding. The number of shares has increased by 35.39% in one year.
| Current Share Class | 31.35M |
| Shares Outstanding | 31.35M |
| Shares Change (YoY) | +35.39% |
| Shares Change (QoQ) | +8.87% |
| Owned by Insiders (%) | 2.65% |
| Owned by Institutions (%) | 79.05% |
| Float | 18.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.44 |
| Forward PS | 10.43 |
| PB Ratio | 1.08 |
| P/TBV Ratio | 1.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.23, with a Debt / Equity ratio of 0.00.
| Current Ratio | 14.23 |
| Quick Ratio | 13.91 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -33.63% and return on invested capital (ROIC) is -23.22%.
| Return on Equity (ROE) | -33.63% |
| Return on Assets (ROA) | -21.86% |
| Return on Invested Capital (ROIC) | -23.22% |
| Return on Capital Employed (ROCE) | -32.01% |
| Weighted Average Cost of Capital (WACC) | 16.83% |
| Revenue Per Employee | $125,579 |
| Profits Per Employee | -$540,309 |
| Employee Count | 152 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, LENZ has paid $502,000 in taxes.
| Income Tax | 502,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.43% in the last 52 weeks. The beta is 2.30, so LENZ's price volatility has been higher than the market average.
| Beta (5Y) | 2.30 |
| 52-Week Price Change | -65.43% |
| 50-Day Moving Average | 10.85 |
| 200-Day Moving Average | 24.99 |
| Relative Strength Index (RSI) | 42.27 |
| Average Volume (20 Days) | 793,755 |
Short Selling Information
The latest short interest is 9.48 million, so 30.23% of the outstanding shares have been sold short.
| Short Interest | 9.48M |
| Short Previous Month | 9.03M |
| Short % of Shares Out | 30.23% |
| Short % of Float | 51.28% |
| Short Ratio (days to cover) | 8.13 |
Income Statement
In the last 12 months, LENZ had revenue of $19.09 million and -$82.13 million in losses. Loss per share was -$2.85.
| Revenue | 19.09M |
| Gross Profit | 18.67M |
| Operating Income | -91.14M |
| Pretax Income | -81.63M |
| Net Income | -82.13M |
| EBITDA | -90.85M |
| EBIT | -91.14M |
| Loss Per Share | -$2.85 |
Full Income StatementBalance Sheet
The company has $292.35 million in cash and $815,000 in debt, with a net cash position of $291.53 million or $9.30 per share.
| Cash & Cash Equivalents | 292.35M |
| Total Debt | 815,000 |
| Net Cash | 291.53M |
| Net Cash Per Share | $9.30 |
| Equity (Book Value) | 284.34M |
| Book Value Per Share | 9.07 |
| Working Capital | 280.23M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$69.17 million and capital expenditures -$827,000, giving a free cash flow of -$70.00 million.
| Operating Cash Flow | -69.17M |
| Capital Expenditures | -827,000 |
| Depreciation & Amortization | 287,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -70.00M |
| FCF Per Share | -$2.23 |
Full Cash Flow StatementMargins
| Gross Margin | 97.81% |
| Operating Margin | -477.46% |
| Pretax Margin | -427.62% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LENZ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -35.39% |
| Shareholder Yield | -35.39% |
| Earnings Yield | -27.87% |
| FCF Yield | -23.75% |
Dividend DetailsAnalyst Forecast
The average price target for LENZ is $44.00, which is 373.63% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $44.00 |
| Price Target Difference | 373.63% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 54.60% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LENZ has an Altman Z-Score of 22.44 and a Piotroski F-Score of 1.
| Altman Z-Score | 22.44 |
| Piotroski F-Score | 1 |
